---
figid: PMC8386298__nihms-1713830-f0002
figtitle: Moving Towards Targeted Therapies for Triple-Negative Breast Cancer
organisms:
- NA
pmcid: PMC8386298
filename: nihms-1713830-f0002.jpg
figlink: /pmc/articles/PMC8386298/figure/F2/
number: F2
caption: 'Mechanism of action of PI3K/AKT/mTOR (PAM) pathway inhibitors and androgen
  receptor blockers. (A) Growth factor binds to growth factor receptor in the tumor
  cell membrane resulting in activation of the PI3K, AKT, and mTOR. Activation of
  mTOR results in protein synthesis and cell growth. PTEN downregulates PI3K and results
  in decreased activation of the PAM pathway. PI3K, AKT, and mTOR inhibitors block
  the activation of this pathway and results in cell death. (B) Androgens bind to
  cytoplasmic androgen receptors resulting in activation. Heat shock proteins bound
  to the androgen receptor dissociate and the androgen receptor dimerizes. The dimer
  is translocated to the nucleus where it binds to the promoter region and results
  in gene transcription. Androgen receptor blockers block androgen binding to androgen
  receptor. PI3K: phosphoinositide 3-kinse, AKT: protein kinase B, mTOR: mechanistic
  target of rapamycin, PTEN: phosphatase and tensin homolog. AR: Androgen receptor,
  HSP: heat shock protein'
papertitle: Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.
reftext: Jodi A. Kagihara, et al. Curr Breast Cancer Rep. ;13(3):216-226.
year: '2021'
doi: 10.1007/s12609-021-00416-0
journal_title: Current breast cancer reports
journal_nlm_ta: Curr Breast Cancer Rep
publisher_name: ''
keywords: triple-negative breast cancer | targeted therapies | immunotherapy | novel
  agents
automl_pathway: 0.9425451
figid_alias: PMC8386298__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8386298__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8386298__nihms-1713830-f0002.html
  '@type': Dataset
  description: 'Mechanism of action of PI3K/AKT/mTOR (PAM) pathway inhibitors and
    androgen receptor blockers. (A) Growth factor binds to growth factor receptor
    in the tumor cell membrane resulting in activation of the PI3K, AKT, and mTOR.
    Activation of mTOR results in protein synthesis and cell growth. PTEN downregulates
    PI3K and results in decreased activation of the PAM pathway. PI3K, AKT, and mTOR
    inhibitors block the activation of this pathway and results in cell death. (B)
    Androgens bind to cytoplasmic androgen receptors resulting in activation. Heat
    shock proteins bound to the androgen receptor dissociate and the androgen receptor
    dimerizes. The dimer is translocated to the nucleus where it binds to the promoter
    region and results in gene transcription. Androgen receptor blockers block androgen
    binding to androgen receptor. PI3K: phosphoinositide 3-kinse, AKT: protein kinase
    B, mTOR: mechanistic target of rapamycin, PTEN: phosphatase and tensin homolog.
    AR: Androgen receptor, HSP: heat shock protein'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - Pten
  - ar
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PTEN
  - AR
  - HSP90B2P
---
